February 23, 2017 / 12:57 PM / 7 months ago

BRIEF-Obalon Therapeutics Q4 loss per share $0.51

Feb 23 (Reuters) - Obalon Therapeutics Inc:

* Obalon Therapeutics Inc announces fourth quarter and full year 2016 financial results

* Q4 loss per share $0.51

* Q4 revenue $800,000 versus I/B/E/S view $697,000

* Q4 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below